+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Reduced calcium binding capacity is an intrinsic abnormality of red blood cell membrane in spontaneously hypertensive rats



Reduced calcium binding capacity is an intrinsic abnormality of red blood cell membrane in spontaneously hypertensive rats



American Journal of Hypertension 3(7): 570-572



Reduced calcium (Ca) binding capacity is a widespread and primary abnormality in SHR. It was reported that in red blood cell (RBC) membranes it is detectable only in membrane preparations containing sealed inside-out vesicles, the formation of which implies the partial removal of cytoskeletal proteins from the RBC membrane. The present study compares the Ca binding capacity of RBC membrane preparations with normal (+CS) and reduced (-CS) cytoskeleton content in SHR and normotensive WKY control rats. In addition to Ca binding capacity and protein content, the cholesterol content and the acetylcholinesterase (ACE) activity were measured as having a quantitative measure of integral membrane components in the different membrane preparations. In both strains the cholesterol/protein ratio, the ACE activity per mg of membrane protein, and the Ca binding capacity were all significantly higher in -CS compared to +CS membrane preparations (P less than .001). A statistically significant difference in Ca binding capacity between SHR and WKY was observed only using -CS membranes preparation. The results support the concept of a reduced membrane Ca binding capacity in rat genetic hypertension: this abnormality is detectable only in membrane preparations with reduced cytoskeletal content.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007729451

Download citation: RISBibTeXText

PMID: 2363898

DOI: 10.1093/ajh/3.7.570


Related references

Decrease of caffeine elimination in man during co administration of 4 quinolones. Journal of Antimicrobial Chemotherapy 20(5): 729-734, 1987

Decrease of caffeine elimination in man during co-administration of 4-quinolones. Journal of Antimicrobial ChemoTherapy 20(5): 729-734, 1987

Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology 20(5): 1073-1080, 1999

Calcium binding to phospholipid: structural study of calcium glycerophosphate. Journal of Lipid Research 33(7): 985-994, 1992

Reduced calcium induced calcium release from skeletal muscle sarcoplasmic reticulum at low ph. Canadian Journal of Physiology and Pharmacology 70(6): 926-930, 1992

Genetic relationship between Paruterinidae from nocturnal birds of prey and Taeniidae from daytime birds of prey. Doklady Akademii Nauk SSSR 220(1): 254-255, 1975

Alterations in calcium phosphorus and carboxyl terminal parathyroid hormone levels in equine acute renal disease. Cornell Veterinarian 76(3): 317-329, 1986

Spontaneously hypertensive rats exhibit an enhanced mydriatic response to clonidine evidence for enhanced sensitivity of central alpha 2 adrenoceptors. Canadian Journal of Physiology and Pharmacology 61(7): 764-766, 1983

Renal abnormalities in patients with sickle cell-beta thalassemia. Journal of Nephrology 10(3): 163-167, 1997

Calcium accumulating structures in a smooth muscle of invertebrates. Protoplasma 67(1): 111-115, 1969

Molecular basis of the abnormal abdomen phenotype in drosophila mercatorum. Genetics 104(1 Part 2): S21, 1983

Effect of high calcium and phosphorus intake on mineral retention in very low birth weight infants chronically treated with furosemide. Journal of Pediatric Gastroenterology and Nutrition 9(2): 206-211, 1989

Calcium currents and peptide release from neurohypophysial terminals are inhibited by ethanol. Journal of Pharmacology and Experimental Therapeutics 259(2): 705-711, 1991

Exaggerated quinidine effects produced by acidosis and hypo kalemia. Clinical Research 29(2): 225A, 1981